abstract |
The invention relates to stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (IFN-beta). The formulations include IFN-beta solubilized in a low ionic strength formulation, keeping the formulation at a pH of about 5.0. The invention also relates to methods for the preparation of these compositions and to increase the solubility of IFN-beta in pharmaceutical compositions. |